Published in Cancer Weekly, March 30th, 2010
"We are extremely pleased with the outcome of this round of financing," said John Cousins, Biomoda president and chief executive officer. "The institutions that participated in this investment speak volumes about the promise of our technology and the validity of our business model and strategy. This is a significant stamp of approval from prestigious investment funds with a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.